$TARS
Tarsus Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$76.69
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTarsus Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is TARS up today? It is at $76.69 (+0.00%), and our scanner flagged it 99 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TARS spikes, and full due diligence on TARS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TARS 99 times in the last 30 days. Create a free account to track $TARS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TARS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TARS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Link William J Phd Director | Sold (automatic/other) | -13K 0.03% of company | sold 12% | 94K | $979K at $78.33 | Sep 15, 26 |
Link William J Phd Director | Other | 201 | added 0.2% | 107K | n/a | Sep 15, 26 |
Yarno Wendy L Director | Other | 302 | added 1.8% | 17K | n/a | Sep 15, 26 |
Pyott David E I Director | Other | 201 | added 2.1% | 10K | n/a | Sep 15, 26 |
Neervannan Seshadri Officer | Sold (automatic/other) | -5K | sold 5.5% | 79K | $388K at $85.00 | Sep 4, 26 |
Lin Elizabeth Yeu Officer | Sold (automatic/other) | -11K 0.02% of company | sold 81% | 3K | $916K at $85.00 | Sep 4, 26 |
Lin Elizabeth Yeu Officer | Sold (automatic/other) | -3K | sold 19% | 14K | $270K at $85.00 | Sep 4, 26 |
Azamian Bobak R. Officer | Sold (automatic/other) | -10K 0.02% of company | sold 1.2% | 828K | $903K at $90.27 | Sep 4, 26 |
Lin Elizabeth Yeu Officer | Sold (automatic/other) | -5K 0.01% of company | sold 29% | 13K | $431K at $80.00 | Sep 2, 26 |
Lin Elizabeth Yeu Officer | Sold (automatic/other) | -2K | sold 8.6% | 17K | $127K at $80.00 | Sep 2, 26 |
Azamian Bobak R. Officer | Sold (automatic/other) | -10K 0.02% of company | sold 1.2% | 838K | $801K at $80.06 | Sep 2, 26 |
Lin Elizabeth Yeu Officer | Sold (automatic/other) | -5K | sold 20% | 19K | $340K at $73.86 | Sep 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on TARS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TARS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TARS last traded at $76.69, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is next expected to report earnings on Tuesday, November 3, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TARS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TARS 99 times in the last 30 days.
TARS (Tarsus Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $3.59B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TARS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TARS discussion
Sign in to ask a question or join the discussion.